MENU
CN
  • The 6th Dongsheng Cup International Entrepreneurship Competition
    “Strength gathering, Dream sailing” On December 11th- 13th , 2018, the 6th "Dongsheng Cup" International Entrepreneurship Competition and the 3rd Zhongguancun Talent Entrepreneurship Competition were held in Dongsheng Gloria Hotel, Dongsheng Technology Park, Zhongguancun, Beijing. The “Dongsheng Cup” International Entrepreneurship Competition has been successfully held for five times since its inception in 2013. It has attracting more than 4,000 outstanding domestic and international entreprene
    Read All
  • Hopstem Biotech at ISSCR2018 Annual Meeting
    Hopstem Biotechnology had a great time at the ISSCR2018 Annual Meeting in Melbourne.The conference was held on the 20th to 23th of June at the Melbourne Convention & Exhibition Centre. The ISSCR annual meeting is The World's Largest Stem Cell-focused Meeting. With more than 3,500 attendees, speakers, exhibitors, sponsors, and media, the meeting brings together everyone from senior scientists to trainees to discover, share, and network with leading innovators in the stem cell community.
    View details 2019-07-03
  • Hopstem Biotechnology at the World Preclinical Congress - iPS Cells for Disease Modeling and Drug Di
    June19-20, Hopstem Biotechnology participated the WPC in the Westin Copley Palace,Boston,MA. Cambridge Healthtech Institute’s Third Annual iPS Cells for Disease Modeling and Drug Discovery conference is designed to bring together experts and bench scientists working with pluripotent cells and end users of their services, researchers working on finding cures for specific diseases and disorders.This opens new and exciting opportunities for pluripotent stem cell utilization in early discovery, prec
    View details 2019-07-03
  • Great Guest From Afar, Happiness As We Are. Member of Royal Canadian Academy of Sciences, Professor
    December 7, 2017, Hopstem Biotechnology Co., Ltd. ushered it’s respectful guest, Dr. Wang Yutian, the Member of Royal Canadian Academy of Sciences, an internationally renowned neurobiologist, who is also a senior science advisor of Hopstem Biotechnology. Dr. Wang was one of Dr. Fan Jing’s PhD supervisors when she was studying in Canada. Mr. Wang Yutian took the opportunity of his visit to China and made a special trip to Hopstem to inspect and advice on Hopstem’s scientific progress. Dr. Fan
    View details 2019-07-03
  • A Kite Chaser: Dialogue Dr. Fan Jing, founder of Hopstem Biotechnology Co., Ltd. Johns Hopkins Unive
    Overview of the venture and innovation: Hopstem Biotechnology Co., Ltd. was founded in Hangzhou in January 2017 jointly by former neuroscience and stem cell scientists of Johns Hopkins University from the United States. Hopstem has world-leading advantages in iPSCc / ESCc neuronal differentiation, gene editing, stem cell storage and cell engineering. Hopstem is committed to using the most advanced stem cell technology to promote the diagnosis and treatment of nervous system diseases and other di
    View details 2019-07-03
  • Hopstem Biotechnology Co., Ltd. delegation attended 2017 the 15th International Symposium
    On November 9, 2017, Golden autumn gave a warm welcome to the 15th International Symposium on New Technologies of Infectious Diseases and the First International Biomedical Engineering Conference in the ancient city of Xi'an. Dr. Fan Jing, general manager of Hodder Company, was invited as the chairwoman of Chinese Forum and gave a keynote speech on "Human Neurological Disease Model and Drug Screening Platform", which described the in vitro humanized disease model, leading drug screening technolo
    View details 2019-07-03
  • Hopstem Biotechnology Co., Ltd. Completed and Unveiled Its New Site
    November 5, 2017, after months of intense preparation, Hopstem Biotechnology Co., Ltd. opened and inaugurated its new site in Hangzhou Zhongzi Economic and Technological Development Park. This is the first high-tech start-up company in China that focuses on iPSCs and neural stem cell storage and differentiation services. In line with the strategic needs of national biomedical innovation, it provides the most comprehensive and advanced frontier technologies for the research and treatment of neuro
    View details 2019-07-03
First 1 2 End